Alpha Tau Medical Ltd. (DRTS)

$3.78

-0.20 (-5.03%)
Rating:
Recommendation:
-
Symbol DRTS
Price $3.78
Beta 0.000
Volume Avg. 0.08M
Market Cap 260.864M
Shares () -
52 Week Range 3.0-20.65
1y Target Est -
DCF Unlevered DRTS DCF ->
DCF Levered DRTS LDCF ->
ROE -
ROA -
Operating Margin -
Debt / Equity 11.29% Neutral
P/E -
P/B -
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades


Healthcare
Biotechnology
NASDAQ Capital Market

Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. The company was incorporated in 2015 and is headquartered in Jerusalem, Israel.